Leveraging the Base Stability of Waters XBridge™ Biphenyl RP Columns with MaxPeak™ Premier Technology for the Chromatographic Separation of Barbiturates

Significance of the topic

The chromatographic separation of barbiturates is analytically challenging because many clinically and forensically relevant barbiturates are structural isomers or near-isomers with very similar hydrophobicity, polarity and ionization behavior. Reliable baseline resolution of these compounds is essential for accurate quantification in clinical, forensic and quality-control laboratories. This study demonstrates how a base-stable biphenyl stationary phase combined with appropriate mobile-phase pH and gradient design provides an effective solution for resolving a five‑component barbiturate panel, including the difficult-to-separate isomers amobarbital and pentobarbital.

Objectives and overview of the study

The main objective was to develop a robust reversed-phase chromatographic method to baseline-resolve five barbiturates (phenobarbital, butalbital, amobarbital, pentobarbital, secobarbital) with emphasis on separating the structural isomers amobarbital and pentobarbital. The approach leveraged the unique selectivity of a biphenyl stationary phase (π–π interactions) and its alkali stability (ethylene-bridged hybrid, BEH particles), permitting exploration of elevated mobile-phase pH to influence ionization and selectivity. Method development prioritized selectivity variables (pH, organic modifier, stationary phase) and included optimization of buffer concentration, column temperature and gradient shape to shorten run time while maintaining separation performance.

Methodology

Sample preparation:

• Working solution prepared at 25 µg/mL by 1:10 dilution of a commercial barbiturate mixture in a diluent matched to the initial mobile phase (methanol plus aqueous ammonium acetate).
• Single-analyte standards at 100 µg/mL were used for peak identification.

Chromatographic strategy and rationale:

• Used a biphenyl stationary phase to exploit π–π interactions that provide selectivity different from C18 phases.
• Methanol was chosen as the organic modifier because it enhances π–π interactions relative to acetonitrile, despite higher viscosity and UV cutoff.
• Ammonium acetate was selected as a volatile, MS-compatible buffer able to maintain pH across acidic and basic ranges (near pH 4.8, 6.9 and 9.3 were tested).
• Investigated buffer concentration (5–20 mM) and column temperature (30 vs 40 °C) to evaluate robustness and any secondary effects on selectivity.

Instrumentation used

Key instruments and consumables used in the study included:

• LC system: ACQUITY UPLC H‑Class Bio System equipped with BioQuaternary Solvent Manager (bioQSM), BioSample Manager Flow‑Through‑Needle (bioSM‑FTN) and single-channel column heater.
• Column: Waters XBridge Biphenyl RP Column, MaxPeak Premier Technology, 2.5 µm, 130 Å, BEH, 2.1 × 50 mm.
• Detector: ACQUITY Photodiode Array (PDA) detector, detection at 220 nm.
• Vials: LCMS-certified TruView pH control glass vials with PTFE/silicone septa.
• Data system: Empower Chromatography Data System (CDS).

Selected chromatographic conditions (optimized):

• Column temperature: 30 °C; sample temperature: 20 °C; flow rate: 400 µL/min; injection volume: 2 µL.
• Mobile phases: A = 10 mM ammonium acetate (aqueous), pH 9.3; D = methanol/100 mM ammonium acetate (90/10, v/v), pH 9.3; C = acetonitrile (wash).
• Optimized gradient: centered the separation on the five‑analyte panel and included an integral high‑organic wash; run time reduced from ~25 min to ~15.5 min by adjusting initial organic content and gradient time.

Main results and discussion

Effect of stationary phase and acidic conditions:

• A conventional silica-based biphenyl column with formic-acid-containing mobile phase provided only partial separation of amobarbital and pentobarbital (resolution Rs ≈ 0.7–0.8), insufficient for reliable quantification.
• The XBridge Biphenyl BEH stationary phase under low-pH conditions performed similarly (Rs ≈ 0.7), indicating selectivity under acidic conditions remained limited for the isomer pair.

Effect of mobile-phase pH:

• Barbiturates are weak acids with pKa values near 7–8; pH strongly influences ionization state and thus retention and selectivity.
• Using ammonium acetate buffers, separations were compared at pH ~4.8, 6.9 and 9.3. At pH 4.8 Rs for the isomer pair was ~0.79; at pH 6.9 Rs rose to ~0.96.
• At pH 9.3 (above analyte pKa), all barbiturates were deprotonated (negatively charged), overall retention decreased and differences in interaction led to greatly improved selectivity: amobarbital and pentobarbital reached baseline resolution with Rs ≈ 3.7.

Other method variables:

• Buffer concentration had little impact on retention/selectivity: lowering ammonium acetate from 20 mM to 5 mM produced minimal change at pH 9.3, indicating ion-exchange interactions were not a dominant retention mechanism under these conditions. A compromise concentration of 10 mM ammonium acetate was selected for MS compatibility and robustness.
• Column temperature (30 vs 40 °C) did not materially improve resolution for the critical isomer pair; a slight retention decrease (4–6%) was observed at the higher temperature but Rs did not improve, so 30 °C was chosen to extend column lifetime.
• Gradient optimization increased initial organic content and shortened gradient time to reduce run time by ≈10 minutes while preserving baseline separation.

Benefits and practical applications

The method and choice of stationary phase offer several practical advantages:

• Base-stable BEH biphenyl stationary phase enables method development at elevated pH (up to pH 10), expanding options to exploit differential ionization for challenging separations that silica-based phases cannot tolerate.
• Biphenyl chemistry introduces π–π interactions that provide orthogonal selectivity to conventional C18 phases, improving separation of closely related aromatic and heteroaromatic analytes.
• Using methanol as organic modifier can strengthen π–π contributions to selectivity, aiding isomer discrimination.
• The optimized method is compatible with LC–MS (volatile buffer, moderate buffer concentration) and yields baseline resolution for quantitation and confirmation in forensic, clinical toxicology and pharmaceutical impurity testing contexts.

Future trends and potential uses

Key directions and opportunities emerging from this work include:

• Broader adoption of base-stable reversed-phase chemistries (BEH-based phases) for separations of ionizable compounds where pH-driven selectivity can be advantageous.
• Systematic exploitation of π–π and other secondary interactions (using phenyl/biphenyl and related chemistries) during early method scouting to reduce method development cycles for isomeric analytes.
• Integration with high-sensitivity MS workflows: further optimization of organic modifiers and buffer systems to maximize MS response while retaining chromatographic selectivity.
• Miniaturization and UHPLC scale-up: applying MaxPeak Premier technology and columns in shorter, smaller-particle formats to achieve fast, high-resolution separations with low extracolumn dispersion.

Conclusion

This application demonstrates that the combination of a base-stable XBridge Biphenyl RP stationary phase (BEH particles with durable trifunctional bonding), a basic ammonium acetate mobile phase (pH 9.3) and an optimized methanol-containing gradient produces baseline separation of a five-barbiturate panel, including the structural isomers amobarbital and pentobarbital (Rs ≈ 3.7). Mobile-phase pH was the dominant factor affecting selectivity; buffer concentration and modest temperature changes had limited effect. The method is robust, MS-compatible and suitable for laboratories that require reliable quantitation of barbiturate isomers.

References

1. Cleveland Clinic. Clinical overview of barbiturates. 2026.
2. Zabala G., et al. A highly stable biphenyl HPLC stationary phase based on ethylene-bridged hybrid particles. Waters Application Note. 2026.
3. Dinesh D., Gokulapriya K., Gowsalya K., Hariharasuthan V., Harini T. A comprehensive review: role of acetonitrile and methanol as mobile phase solvents in RP-HPLC. IJRPR. 2025;6(9):1188–1193.
4. Neue U.D., Mendez A. Selectivity in reversed-phase separations: general influence of solvent type and mobile phase pH. Journal of Separation Science. 2007;30:949–963.
5. Wachełko O., Tusiewicz K., Zawadzki M., Szpot P. New approach for barbiturates, phenytoin, methyprylon and glutethimide determination and fragmentation (UHPLC-MS/MS). Journal of Pharmaceutical and Biomedical Analysis. 2023;228:115318.